Facebook-f X-twitter Youtube Linkedin-in
Home Safety Alert Suspected Adverse Drug Reactions of Angiotensin 11 converting enzyme inhibitors reported to BoMRA

Suspected Adverse Drug Reactions of Angiotensin 11 converting enzyme inhibitors reported to BoMRA

Suspected Adverse Drug Reactions of Angiotensin 11 converting enzyme inhibitors reported to BoMRA

Botswana Medicines Regulatory Authority (BoMRA) continues to monitor safety of medicinal products registered in Botswana. One of the key activities is to advocate for adverse drug reactions (ADRs) reporting, assessment, and analysis. BoMRA has analyzed safety reports associated with angiotensin converting enzyme inhibitors (ACEIs) received between 1st April 2019 and 28th February 2023.

Suspected Adverse Drug Reactions of Angiotensin 11 converting enzyme inhibitors reported to BoMRADownload
Facebook-f X-twitter Youtube Linkedin-in

Social Media

More Posts

No spam, notifications only about new products, updates.

Most vaccines are safe and well tolerated. However, if you experience any discomfort after vaccination, seek immediate medical attention and ask your healthcare provider to report the event to BoMRA

Botswana Medicines Regulatory Authority
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.